Hawaii Association of Professional Nurses

New Oral Antibiotics Data: ABSSSI Treatment Information

Posted about 3 years ago by Rick Ramirez in Education

The Expert Update on Acute Bacterial Skin and Skin Structure Infections: Treatment Options in the Community Setting

  • Authors: George Sakoulas, MD; Paul Doghramji, MD; Larissa May, MD, MSPH, MSHS
  • CME / ABIM MOC / CE Released: 9/27/2021
  • Valid for credit through: 9/27/2022
  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    You Are Eligible For

    • ANCC Contact Hour(s)

Target Audience and Goal Statement

This activity is intended for primary care physicians, infectious disease specialists, emergency medicine physicians, and nurses.

The goal of this activity is to improve healthcare providers’ knowledge on the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI) in the outpatient setting as well as how to best incorporate novel antimicrobials into patient care plans.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Identification of patients who can be treated for ABSSSI in the outpatient setting
    • Latest data on new oral antibiotics used in the treatment of ABSSSI
  • Have greater competence related to
    • Determining a patient care strategy for ABSSSI in the community

Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • George Sakoulas, MD

    Adjunct Professor of Pediatrics
    Division of Host-Microbe Systems and Therapeutics
    University of California San Diego School of Medicine
    Infectious Disease Consultant
    Sharp Healthcare
    La Jolla, California

    Disclosure: George Sakoulas, MD, has the following relevant financial relationships:
    Advisor or consultant for: AbbVie; Ferring; Paratek
    Speaker or a member of a speakers bureau for: AbbVie; Paratek
    Grants for clinical research from: Octapharma
    Royalties or patent beneficiary: UpToDate

  • Paul Doghramji, MD

    Family Physician
    Collegeville Family Practice
    Medical Director of Health Services
    Ursinus College
    Collegeville, Pennsylvania

    Disclosure: Paul Doghramji, MD, has the following relevant financial relationships:
    Advisor or consultant for: Eisai
    Speaker or a member of a speakers bureau for: Allergan; Eisai; Lilly
    Stocks, stock options, or bonds from: CVS; Pfizer

  • Larissa May, MD, MSPH, MSHS

    Professor of Emergency Medicine
    Director of ED and Outpatient Antibiotic Stewardship
    Medical Director
    Learning Health System Hub
    UC Davis Health
    Antibiotic Stewardship Lead
    VA Northern California Healthcare System
    Sacramento, California

    Disclosure: Larissa May, MD, MSPH, MSHS, has the following relevant financial relationships:
    Advisor or consultant for: Abbott; BioRad; Cepheid; Health Advances; Hitachi Chemical; Roche Diagnostics; Roche Molecular Systems; Qvella; Talis
    Speaker or a member of a speakers bureau for: Cepheid; Inflammatix; Roche Diagnostics; Roche Molecular Systems; Thermofisher
    Grants for clinical research from: Gilead; Inflammatix; Merck; Roche Diagnostics; Roche Molecular Systems

Editor

  • Karen Badal, MD, MPH

    Senior Medical Education Director, Medscape, LLC

    Disclosure: Karen Badal, MD, MPH, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.


Accreditation Statements